Ethical Considerations for the Use of Next-Generation Alzheimer Drugs in Symptomatic and At-Risk Patients.

TitleEthical Considerations for the Use of Next-Generation Alzheimer Drugs in Symptomatic and At-Risk Patients.
Publication TypeJournal Article
Year of Publication2016
AuthorsGauthier S, Rosa-Neto P, Kass JS
JournalContinuum (Minneap Minn)
Volume22
Issue2 Dementia
Pagination615-8
Date Published2016 Apr
ISSN1538-6899
KeywordsAged, Alzheimer Disease, Antipsychotic Agents, Cognition Disorders, Ethics, Medical, Female, Humans
Abstract

This article presents a case in which a patient with mild Alzheimer disease requests a prescription for a newly developed Alzheimer disease drug, after which the patient's daughter inquires about its potential usefulness as a prevention strategy for herself. The article discusses the physician's responsibility to balance the ethical principles of beneficence, nonmaleficence, and respect for patient autonomy when evaluating requests for medications from patients with neurocognitive disease as well as from asymptomatic but at-risk patients.

DOI10.1212/CON.0000000000000306
Alternate JournalContinuum (Minneap Minn)
PubMed ID27042911
Grant List / / Canadian Institutes of Health Research / Canada


  • Douglas Hospital
  • Dobell Pavillion
  • Brain imaging centre